Corrigendum to CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
- Published in:
- 2022
- Publication type:
- Correction Notice
Works matching IS 09612033 AND DT 2022 AND VI 31 AND IP 5
Results: 16
1
2
Early detect left ventricular subclinical myocardial dysfunction in patients with systemic lupus erythematosus by a left ventricular pressure-strain loop.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 596, doi. 10.1177/09612033221089150
- By:
- Publication type:
- Article
3
Refractory antiphospholipid antibody syndrome–induced thrombocytopaenia successfully treated with belimumab.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
4
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 588, doi. 10.1177/09612033221088437
- By:
- Publication type:
- Article
5
Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 606, doi. 10.1177/09612033221088207
- By:
- Publication type:
- Article
6
Retrobulbar blood flow velocity in systemic lupus erythematosus assessed by color Doppler imaging.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 582, doi. 10.1177/09612033221088181
- By:
- Publication type:
- Article
7
Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 575, doi. 10.1177/09612033221086878
- By:
- Publication type:
- Article
8
Dilated cardiomyopathy: An unusual and severe condition in juvenile systemic lupus erythematosus.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
9
CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 565, doi. 10.1177/09612033221086134
- By:
- Publication type:
- Article
10
The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 555, doi. 10.1177/09612033221086123
- By:
- Publication type:
- Article
11
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 532, doi. 10.1177/09612033221084518
- By:
- Publication type:
- Article
12
Research progress of BK virus and systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 522, doi. 10.1177/09612033221084259
- By:
- Publication type:
- Article
13
Pelvic deep venous thrombosis mimicking lower limb cellulitis in systemic lupus erythematosus-associated antiphospholipid syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
14
Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 541, doi. 10.1177/09612033221084222
- By:
- Publication type:
- Article
15
Multicenter lupus register from Argentina, the RELESSAR database: Influence of ethnicity on disease phenotype.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 637, doi. 10.1177/09612033221083267
- By:
- Publication type:
- Article
16
Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 628, doi. 10.1177/09612033221081691
- By:
- Publication type:
- Article